Steven Dyckman
Child & Adolescent Psychiatry · East Brunswick, NJNPI 1396864385
Payments from drug & device makers
Across 888 payments — averaging $59.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$41K
- Corium, LLC$4K
- Supernus Pharmaceuticals, Inc.$1K
- Sunovion Pharmaceuticals Inc.$1K
- Otsuka America Pharmaceutical, Inc.$950
- Takeda Pharmaceuticals U.S.A., Inc.$799
- plus $3K from 21 others
What the payments were for
- Consulting fees$4,1608%
- Speaking & faculty fees$39,04273%
- Travel & lodging$840%
- Food & beverage$9,87119%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 321 | $41,014 |
| Corium, LLC | 24 | $4,448 |
| Supernus Pharmaceuticals, Inc. | 37 | $1,419 |
| Sunovion Pharmaceuticals Inc. | 75 | $1,168 |
| Otsuka America Pharmaceutical, Inc. | 85 | $950 |
| Takeda Pharmaceuticals U.S.A., Inc. | 80 | $799 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 52 | $630 |
| Lundbeck LLC | 45 | $468 |
| Tris Pharma Inc | 29 | $393 |
| Axsome Therapeutics, Inc. | 24 | $307 |
| Neos Therapeutics, LP | 25 | $261 |
| Alkermes, Inc. | 15 | $217 |
| Neurocrine Biosciences, Inc. | 13 | $199 |
| Teva Pharmaceuticals USA, Inc. | 10 | $154 |
| Bausch Health US, LLC | 10 | $152 |
| Adlon Therapeutics L.p. | 7 | $90 |
| Ironshore Pharmaceuticals Inc. | 6 | $83 |
| Idorsia Pharmaceuticals US Inc | 5 | $78 |
| Vanda Pharmaceuticals Inc. | 5 | $74 |
| Jazz Pharmaceuticals Inc. | 5 | $63 |
| Eisai Inc. | 4 | $53 |
| Vertical Pharmaceuticals, LLC | 3 | $44 |
| Johnson & Johnson | 3 | $41 |
| Rhodes Pharmaceuticals L.p. | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$53,181 in reported general payments places this provider in the 95th percentile of 137 child & adolescent psychiatry providers in New Jersey.
See all child & adolescent psychiatry providers in New Jersey →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $91,030 |
| TrintellixVortioxetine Hydrobromide | 53 | $31,713 |
| XanaxAlprazolam | 24 | $20,449 |
| RexultiBrexpiprazole | 12 | $15,837 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,089 |
| Bupropion XlBupropion Hcl | 85 | $2,866 |
| Dextroamphetamine Sulfate | 12 | $1,925 |
| Sertraline Hcl | 129 | $1,638 |
| Escitalopram Oxalate | 76 | $1,264 |
| Doxepin Hcl | 17 | $1,226 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 50 | $1,201 |
| Risperidone | 18 | $1,049 |
| Alprazolam | 121 | $711 |
| Clonazepam | 54 | $670 |
| Quetiapine Fumarate | 46 | $657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $199 | $91,03012 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $799 | $35,80264 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $950 | $15,83712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 137 child & adolescent psychiatry providers in New Jersey.
Other child & adolescent psychiatry in East Brunswick
- Ravinder BhallaRidgewood$125K
- David KrefetzClementon$122K
- Tahir KhwajaNorth Brunswick$59K
- Eric BartkyLivingston$51K
- Bohdan CzartoryskyParsippany$21K
- Akhtar HossainSomerville$19K
- Suzanne LindNew Brunswick$18K
- Aykut OzdenEdgewater$17K
- Valeria KorshunovaHackensack$12K
- Carol DobrzynskiBrick$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.